Hepatitis C virus related lymphoproliferative disorder in a renal transplant recipient

被引：3

作者：

Aravindan, A. N. ^{[1
]}

Moger, Venkatesh ^{[1
]}

Sakhuja, Vinay ^{[1
]}

Kohli, Harbir S. ^{[1
]}

Varma, Neelam ^{[1
]}

Jha, Vivekanand ^{[1
]}

机构：

[1] Postgrad Inst Med Educ & Res, Dept Nephrol, Chandigarh 160012, India

来源：

INTERNATIONAL UROLOGY AND NEPHROLOGY | 2006年 / 38卷 / 02期

关键词：

kidney transplantation; posttransplant lymphoproliferative disorder; hepatitis C; immunosuppression;

D O I：

10.1007/s11255-006-0050-1

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Posttransplant lymphoproliferative disorders (PTLD) are commonly caused by Ebstein-Barr Virus infection. The role of hepatitis C virus (HCV) in the genesis of lymphomas has been recognized recently. We report a HCV infected renal transplant recipient who developed PTLD II months after transplantation. Reduction of immunosuppression led to disappearance of viremia and clearance of PTLD. This is the first such report in the world literature.

引用

页码：355 / 357

页数：3

共 10 条

[1]

BUDA A, 2000, TRANSPL INT S1, V13, P402

[2] Risk factors for lymphoproliferative disorders after liver transplantation in adults:: An analysis of 480 patients [J].

Duvoux, C ;

Pageaux, GP ;

Vanlemmens, C ;

Roudot-Thoraval, F ;

Vincens-Rolland, AL ;

Hézode, C ;

Gaulard, P ;

Miguet, JP ;

Larrey, D ;

Dhumeaux, D ;

Cherqui, D .

TRANSPLANTATION, 2002, 74 (08) :1103-1109

[3] Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection [J].

Hermine, O ;

Lefrère, F ;

Bronowicki, JP ;

Mariette, X ;

Jondeau, K ;

Eclache-Saudreau, V ;

Delmas, B ;

Valensi, F ;

Cacoub, P ;

Brechot, C ;

Varet, B ;

Troussard, X .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (02) :89-94

[4] Role of hepatitis C virus in lymphoproliferative disorders after liver transplantation [J].

Hézode, C ;

Duvoux, C ;

Germanidis, G ;

Roudot-Thoraval, F ;

Vincens, AL ;

Gaulard, P ;

Cherqui, D ;

Pawlotsky, JM ;

Dhumeaux, D .

HEPATOLOGY, 1999, 30 (03) :775-778

[5]

Izumi Tohru, 1997, Leukemia (Basingstoke), V11, P516

[6] Increased risk for posttransplant lymphoproliferative disease in recipients of liver transplants with hepatitis C [J].

McLaughlin, K ;

Wajstaub, S ;

Marotta, P ;

Adams, P ;

Grant, DR ;

Wall, WJ ;

Jevnikar, AM ;

Rizkalla, KS .

LIVER TRANSPLANTATION, 2000, 6 (05) :570-574

[7] Viruses and lymphomas [J].

Pagano, JS .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (02) :78-79

[8] Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma [J].

Silvestri, F ;

Barillari, G ;

Fanin, R ;

Salmaso, F ;

Pipan, C ;

Falasca, E ;

Puglisi, F ;

Mariuzzi, L ;

Zaja, F ;

Infanti, L ;

Patriarca, F ;

Candoni, A ;

Rogato, A ;

Di Loreto, C ;

Botta, GA ;

Baccarani, M .

ANNALS OF ONCOLOGY, 1998, 9 (05) :499-504

[9] The effect of antiviral therapy on t(14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection [J].

Zuckerman, E ;

Zuckerman, T ;

Sahar, D ;

Streichman, S ;

Attias, D ;

Sabo, E ;

Yeshurun, D ;

Rowe, JM .

BLOOD, 2001, 97 (06) :1555-1559

[10] Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma [J].

Zuckerman, E ;

Zuckerman, T ;

Levine, AM ;

Douer, D ;

Gutekunst, K ;

Mizokami, M ;

Qian, DG ;

Velankar, M ;

Nathwani, BN ;

Fong, TL .

ANNALS OF INTERNAL MEDICINE, 1997, 127 (06) :423-428

← 1 →